{
  "title": "Sympathomimetics",
  "questions": [
    {
      "question": "1. What are sympathomimetics?",
      "options": [
        "Drugs that produce actions similar to sympathetic nerve stimulation",
        "Drugs that block parasympathetic receptors",
        "Drugs that inhibit central nervous system activity",
        "Drugs that suppress adrenal function"
      ],
      "correct": 0
    },
    {
      "question": "2. According to chemistry, sympathomimetics are classified into:",
      "options": [
        "Catecholamines and non-catecholamines",
        "Direct and indirect agents",
        "Alpha and beta agonists",
        "Synthetic and natural compounds"
      ],
      "correct": 0
    },
    {
      "question": "3. Which of the following drugs is a catecholamine?",
      "options": [
        "Adrenaline (epinephrine)",
        "Ephedrine",
        "Amphetamine",
        "Cocaine"
      ],
      "correct": 0
    },
    {
      "question": "4. Which of the following is a non-catecholamine sympathomimetic?",
      "options": [
        "Noradrenaline",
        "Adrenaline",
        "Ephedrine",
        "Dobutamine"
      ],
      "correct": 2
    },
    {
      "question": "5. Catecholamines are characterized by:",
      "options": [
        "Poor oral absorption and inability to cross the blood-brain barrier",
        "Good oral absorption and ability to cross the blood-brain barrier",
        "Rapid metabolism by cytochrome P450 enzymes",
        "High lipid solubility with extensive tissue distribution"
      ],
      "correct": 0
    },
    {
      "question": "6. Non-catecholamine sympathomimetics are generally:",
      "options": [
        "Poorly absorbed orally",
        "Incapable of crossing the blood-brain barrier",
        "Well absorbed orally and able to cross the blood-brain barrier",
        "Rapidly degraded by MAO and COMT"
      ],
      "correct": 2
    },
    {
      "question": "7. According to mechanism of action, sympathomimetics are divided into:",
      "options": [
        "Direct, indirect, and dual acting agents",
        "Alpha and beta agonists only",
        "Central and peripheral agents",
        "Agonists and antagonists"
      ],
      "correct": 0
    },
    {
      "question": "8. Direct sympathomimetics act by:",
      "options": [
        "Directly stimulating adrenoreceptors",
        "Inhibiting the reuptake of noradrenaline",
        "Releasing stored noradrenaline from nerve endings",
        "Blocking catecholamine metabolism"
      ],
      "correct": 0
    },
    {
      "question": "9. Which of the following is an example of a direct, non-specific sympathomimetic?",
      "options": [
        "Adrenaline",
        "Ephedrine",
        "Amphetamine",
        "Cocaine"
      ],
      "correct": 0
    },
    {
      "question": "10. Adrenaline exerts its effects by stimulating which receptors?",
      "options": [
        "Alpha receptors only",
        "Beta receptors only",
        "Both alpha and beta receptors",
        "Dopaminergic receptors only"
      ],
      "correct": 2
    },
    {
      "question": "11. When used locally, adrenaline causes vasoconstriction in the nasal mucosa primarily via which receptor?",
      "options": [
        "Alpha1 receptors",
        "Beta1 receptors",
        "Beta2 receptors",
        "Alpha2 receptors"
      ],
      "correct": 0
    },
    {
      "question": "12. Systemically, adrenaline increases heart rate by acting on:",
      "options": [
        "Beta1 receptors",
        "Beta2 receptors",
        "Alpha1 receptors",
        "Alpha2 receptors"
      ],
      "correct": 0
    },
    {
      "question": "13. The phenomenon of 'adrenaline reversal' occurs when:",
      "options": [
        "Alpha blockade unmasks beta2-mediated vasodilation, causing hypotension",
        "Beta blockade unmask alpha-mediated vasoconstriction, causing hypertension",
        "Adrenaline loses its receptor affinity over time",
        "Repeated doses lead to desensitization without any effect on blood pressure"
      ],
      "correct": 0
    },
    {
      "question": "14. In the eye, adrenaline causes mydriasis primarily by stimulating:",
      "options": [
        "Alpha1 receptors",
        "Beta1 receptors",
        "Beta2 receptors",
        "Muscarinic receptors"
      ],
      "correct": 0
    },
    {
      "question": "15. Adrenaline’s bronchodilator effect is mediated by which receptor subtype?",
      "options": [
        "Beta1 receptors",
        "Beta2 receptors",
        "Alpha1 receptors",
        "Alpha2 receptors"
      ],
      "correct": 1
    },
    {
      "question": "16. How does adrenaline increase blood glucose levels?",
      "options": [
        "By stimulating hepatic glycogenolysis and reducing peripheral glucose uptake",
        "By increasing insulin secretion",
        "By inhibiting gluconeogenesis",
        "By promoting adipose tissue glucose uptake"
      ],
      "correct": 0
    },
    {
      "question": "17. Indirect sympathomimetics act by:",
      "options": [
        "Directly stimulating adrenoreceptors",
        "Releasing noradrenaline from nerve endings or inhibiting its reuptake",
        "Blocking adrenoreceptor function",
        "Inhibiting catecholamine synthesis"
      ],
      "correct": 1
    },
    {
      "question": "18. Which drug is an indirect sympathomimetic that increases the release of noradrenaline?",
      "options": [
        "Amphetamine",
        "Adrenaline",
        "Dobutamine",
        "Isoprenaline"
      ],
      "correct": 0
    },
    {
      "question": "19. Cocaine acts as an indirect sympathomimetic by:",
      "options": [
        "Inhibiting noradrenaline reuptake",
        "Directly stimulating beta receptors",
        "Releasing stored noradrenaline",
        "Blocking alpha receptors"
      ],
      "correct": 0
    },
    {
      "question": "20. Dual acting sympathomimetics exhibit:",
      "options": [
        "Both direct receptor stimulation and indirect release of noradrenaline",
        "Only direct receptor stimulation",
        "Only indirect release of noradrenaline",
        "No direct receptor activity"
      ],
      "correct": 0
    },
    {
      "question": "21. Ephedrine is an example of a dual acting sympathomimetic because it:",
      "options": [
        "Acts solely by releasing noradrenaline",
        "Acts solely by directly stimulating receptors",
        "Exhibits both direct stimulation and indirect noradrenaline release",
        "Inhibits catecholamine metabolism"
      ],
      "correct": 2
    },
    {
      "question": "22. One clinical use of dual acting sympathomimetics is:",
      "options": [
        "Prophylaxis for mild chronic bronchial asthma",
        "Treatment of acute myocardial infarction",
        "Management of severe hypertension",
        "Sedation in intensive care"
      ],
      "correct": 0
    },
    {
      "question": "23. Dual acting sympathomimetics can cause CNS stimulation manifesting as:",
      "options": [
        "Insomnia and anxiety",
        "Sedation and lethargy",
        "Hypothermia",
        "Bradycardia"
      ],
      "correct": 0
    },
    {
      "question": "24. Between ephedrine and pseudoephedrine, which is more likely to cause CNS stimulation?",
      "options": [
        "Ephedrine",
        "Pseudoephedrine",
        "Both equally",
        "Neither causes CNS stimulation"
      ],
      "correct": 0
    },
    {
      "question": "25. Catecholamines are generally not absorbed orally because they:",
      "options": [
        "Are degraded in the gastrointestinal tract",
        "Have high lipid solubility",
        "Are resistant to enzymatic degradation",
        "Readily cross the blood-brain barrier"
      ],
      "correct": 0
    },
    {
      "question": "26. Which of the following is a selective β1 agonist used in cardiogenic shock?",
      "options": [
        "Dobutamine",
        "Adrenaline",
        "Isoprenaline",
        "Norepinephrine"
      ],
      "correct": 0
    },
    {
      "question": "27. Beta2-selective agonists used in bronchial asthma include:",
      "options": [
        "Salbutamol and terbutaline",
        "Adrenaline and noradrenaline",
        "Ephedrine and pseudoephedrine",
        "Dobutamine and isoprenaline"
      ],
      "correct": 0
    },
    {
      "question": "28. Which of the following is a long-acting beta2 agonist?",
      "options": [
        "Salmeterol",
        "Terbutaline",
        "Albuterol",
        "Isoprenaline"
      ],
      "correct": 0
    },
    {
      "question": "29. Which beta2 agonist is used in the management of premature labor?",
      "options": [
        "Retrodrine",
        "Salbutamol",
        "Terbutaline",
        "Albuterol"
      ],
      "correct": 0
    },
    {
      "question": "30. Isoxuprine and nylidrine are primarily used to treat:",
      "options": [
        "Peripheral vascular diseases",
        "Hypertension",
        "Cardiac arrhythmias",
        "Gastrointestinal motility disorders"
      ],
      "correct": 0
    },
    {
      "question": "31. Which drug is an alpha1 agonist used to treat hypotension?",
      "options": [
        "Phenylephrine",
        "Adrenaline",
        "Isoprenaline",
        "Dobutamine"
      ],
      "correct": 0
    },
    {
      "question": "32. Long-term use of topical alpha1 agonists in the nasal mucosa can lead to:",
      "options": [
        "Mucosal atrophy and rebound congestion",
        "Enhanced sense of smell",
        "Permanent vasodilation",
        "Decreased risk of infections"
      ],
      "correct": 0
    },
    {
      "question": "33. Indirect sympathomimetics act primarily by:",
      "options": [
        "Increasing the release of noradrenaline",
        "Directly stimulating adrenoreceptors",
        "Blocking noradrenaline receptors",
        "Inhibiting catecholamine synthesis"
      ],
      "correct": 0
    },
    {
      "question": "34. Cocaine’s sympathomimetic effect is due to its ability to:",
      "options": [
        "Inhibit the reuptake of noradrenaline",
        "Directly stimulate beta receptors",
        "Release noradrenaline from storage vesicles",
        "Block alpha receptors"
      ],
      "correct": 0
    },
    {
      "question": "35. Dual acting sympathomimetics are characterized by:",
      "options": [
        "Developing tolerance and tachyphylaxis",
        "No tolerance or tachyphylaxis",
        "Only direct receptor stimulation",
        "Only indirect effects"
      ],
      "correct": 0
    },
    {
      "question": "36. Isoprenaline primarily stimulates which receptors?",
      "options": [
        "Beta receptors (B1 and B2) with no alpha effect",
        "Alpha receptors only",
        "Dopaminergic receptors",
        "Muscarinic receptors"
      ],
      "correct": 0
    },
    {
      "question": "37. What is the clinical use of dobutamine?",
      "options": [
        "To improve cardiac contractility in cardiogenic shock",
        "To treat bronchial asthma",
        "To reduce blood pressure in hypertension",
        "To induce sedation in the intensive care unit"
      ],
      "correct": 0
    },
    {
      "question": "38. A common adverse effect of systemic adrenaline administration is:",
      "options": [
        "Hypotension due to unmasked beta2-mediated vasodilation after alpha blockade",
        "Bradycardia due to direct beta1 stimulation",
        "Severe sedation",
        "Persistent cough"
      ],
      "correct": 0
    },
    {
      "question": "39. Which therapeutic use is NOT typically associated with adrenaline?",
      "options": [
        "Treatment of anaphylactic shock",
        "Local hemostasis in epistaxis",
        "Management of hypertensive crisis",
        "Inhalation therapy for acute bronchial asthma"
      ],
      "correct": 2
    },
    {
      "question": "40. After sympathectomy, the response to dual acting sympathomimetics is:",
      "options": [
        "Increased (supersensitivity)",
        "Decreased due to receptor downregulation",
        "Unchanged",
        "Eliminated entirely"
      ],
      "correct": 0
    }
  ]
}